[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625984":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":33,"locations":42,"responsibleParty":56,"collaborators":25,"id":59,"slug":25,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":25,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":25,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":83,"whyStopped":25,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Mansoura University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Solifenacin Combined with Gabapentin","EXPERIMENTAL","using solifenacin combined with gabapentin for treatment of non-neurogenic overactive bladder in women",[13],"Drug: solifenacin combined with gabapentin",{"label":15,"type":16,"description":17,"interventionNames":18},"solifenacin monotherapy","SHAM_COMPARATOR","solifenacin monotherapy for treatment of non-neurogenic overactive bladder in women",[19],"Drug: solifenacin monotherapy",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DRUG","solifenacin combined with gabapentin",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":27,"otherNames":25},[15],[29],{"name":30,"affiliation":31,"role":32},"Urology and Nephrology center - Mansoura University","urology and nephrology center mansoura university","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":25,"email":38},"Mohamed Elmaghawry, Resident","CONTACT","+201125334957","m7md.gano2016@gmail.com",{"name":40,"role":36,"phone":25,"phoneExt":25,"email":41},"Mohamed Hegazy, Lecturer","hegazym912@gmail.com",[43],{"facility":30,"status":25,"city":44,"state":25,"zip":25,"country":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Al Mansurah","Egypt",{"type":47,"coordinates":48},"Point",[49,50],31.38069,31.03637,{"lat":50,"lon":49},[53],{"name":30,"role":36,"phone":54,"phoneExt":25,"email":55},"+20502202222","unc@mans.edu.eg",{"type":32,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Mohammed Hegazy","lecturer of urology","100625984",false,"NCT07429734","Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women","Efficacy and Tolerability of Solifenacin Combined With Gabapentin Versus Solifenacin Monotherapy for the Treatment of Non-neurogenic Overactive Bladder in Women: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Overactive bladder symptom score (OABSS) \\> 5, urgency subscore ≥3, and urge incontinence score≥ 2.\n\nExclusion Criteria:\n\n* Active urinary tract infection\n* Neurogenic bladder\n* History of genitourinary malignancy\n* Stress urinary incontinence (SUI) as primary diagnosis, or mixed urinary incontinence with predominant SUI\n* Any psychological or psychiatric disorders","FEMALE","18 Years",{"count":68,"type":69},60,"ESTIMATED","INTERVENTIONAL",[72],"PHASE3","The goal of the study is to compare the efficacy, safety and tolerability of solifenacin plus gabapentin versus solifenacin monotherapy for the treatment of women who are suffering from non-neurogenic ОАВ.\n\nThe main questions it aims to answer are:\n\nDoes combination of Solifenacin and Gabapentin affect the total score and sub-scores of OABSS in females with non-neurogenic ОАВ ? What medical problems do participants have when taking combination of Solifenacin and gabapentin ?",[75],"Overactive Bladder",[77,78,79,80,81,82],"overactive bladder","non-neurogenic","gabapentin","solifenacin","anticholinergic","Randomized Controlled Trial","NOT_YET_RECRUITING","2026-02-23",{"date":86,"type":87},"2026-02-24","ACTUAL",{"date":89,"type":69},"2026-02",{"date":91,"type":69},"2027-01",{"name":5,"class":6},1]